AI assistant
Thor Medical ASA — Proxy Solicitation & Information Statement 2026
Apr 1, 2026
3679_rns_2026-04-01_4312c22f-7097-4c46-ad44-75ff012864ee.pdf
Proxy Solicitation & Information Statement
Open in viewerOpens in your device viewer
thor medical
Thor Medical ASA - Notice of Annual General Meeting on 23 April 2026
1.4.2026 08:00:00 CEST | Thor Medical ASA | Additional regulated information required to be disclosed under the laws of a member state
Notice is given that the Annual General Meeting of Thor Medical ASA will be held on 23 April 2026, at 14:00 hours CEST at Advokatfirmaet Selmer, Ruseløkkveien 14, 0251 Oslo. The full notice and appendices are attached. The notice and the documents to which it refers are also available on www.thormedical.com.
DISCLOSURE REGULATION
This information is required to be disclosed under Section 5-12 of the Securities Trading Act.
For further information please contact:
Mathias Nilsen Reierth
Head of Communications and Corporate Affairs
Tel: +47 988 05 724
About Thor Medical ASA
Thor Medical is an emerging supplier of radionuclides, primarily alpha particle emitters, from naturally occurring thorium. Its proprietary production process requires no irradiation or use of nuclear reactors, and provides reliable, environmentally friendly, cost-efficient supply of alpha-emitters for the radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.
To learn more, visit www.thormedical.com
Attachments
- Download announcement as PDF.pdf
- Thor Medical - Proposed resolutions for the AGM 2026 English.pdf
- Thor Medical - Proposed resolutions for the AGM 2026 Norsk.pdf
- Thor Medical - Notice of AGM 2026 English.pdf
- Thor Medical - Notice of AGM 2026 Norsk.pdf